SCHEMBL4328787

SCHEMBL4328787

Cc1ccc(OCC(=O)Nc2cccc(CC(OC(C)C)C(=O)O)c2)cc1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.57
TP53 P04637 1/20 0.57
HIF1A Q16665 1/20 0.56
EPAS1 Q99814 1/20 0.56
MAPK1 P28482 1/20 0.55
MAPT P10636 4/20 0.53
NPC1 O15118 3/20 0.53
RAB9A P51151 2/20 0.53
KDM4E B2RXH2 1/20 0.53
TSHR P16473 1/20 0.53
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
PARP1 P09874 2/20 0.49
HAVCR2 Q8TDQ0 1/20 0.49
HPGD P15428 2/20 0.49
POLB P06746 1/20 0.48
HTT P42858 1/20 0.48
FFAR1 O14842 1/20 0.47
P2RY14 Q15391 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4336619 0.89 HIF1A (0.61) SMN1; SMN2HIF1AEPAS1MAPK1MAPT
SCHEMBL4335055 0.88 SMN1; SMN2 (0.52) SMN1; SMN2HIF1AEPAS1MAPK1MAPT
SCHEMBL4328777 0.80 RAB9A (0.54) SMN1; SMN2TP53MAPTNPC1RAB9A
SCHEMBL4336526 0.80 PPARG (0.45) SMN1; SMN2TP53MAPTNPC1RAB9A
SCHEMBL4334569 0.78 PPARG (0.48) MEN1KMT2A
SCHEMBL4334574 0.78 PPARG (0.48) MEN1KMT2A
SCHEMBL4334564 0.78 PPARG (0.48) MEN1KMT2A
SCHEMBL4339204 0.77 MGLL (0.47) SMN1; SMN2TP53MAPK1MAPTNPC1
SCHEMBL13985697 0.77 MAPK1 (0.84) SMN1; SMN2TP53HIF1AEPAS1MAPK1
SCHEMBL13819357 0.76 MAOB (0.53) SMN1; SMN2TSHRFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 SMN1; SMN2 3054/4885TP53 4574/4885HIF1A 447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.